Noam Hirschberger serves in the Forensic, Litigation and Valuation Group with 15 years of experience developing advanced financial models, including discounted cash flow, comparable security and Black-Scholes analyses, used for valuation of businesses, intangible assets and derivatives.
Noam has an extensive background serving the cannabis industry, with experience working with dispensaries, lifestyle branding companies, cultivators, and biotechnology companies. Additionally, he serves a wide range of investment companies such as private equity groups, hedge funds, BDC’s and other investment companies.
Noam has reviewed and performed numerous valuations of investments for compliance with ASC 820. He has also presented lectures and webinars on best practices for performing valuations pursuant to GAAP.